Participation of an early component of complement and Hageman factor in C3 destruction by zymosan
- 1 July 1975
- journal article
- research article
- Published by Elsevier in Clinical Immunology and Immunopathology
- Vol. 4 (2), 189-198
- https://doi.org/10.1016/0090-1229(75)90054-9
Abstract
No abstract availableThis publication has 13 references indexed in Scilit:
- A SERUM FACTOR IN CHRONIC HYPOCOMPLEMENTEMIC NEPHRITIS DISTINCT FROM IMMUNOGLOBULINS AND ACTIVATING THE ALTERNATE PATHWAY OF COMPLEMENTThe Journal of Experimental Medicine, 1974
- PREKALLIKREIN DEFICIENCY IN MANThe Journal of Experimental Medicine, 1973
- C3 PROACTIVATOR CONVERTASE AND ITS MODE OF ACTIONThe Journal of Experimental Medicine, 1972
- MODULATION OF FUNCTION OF THE ACTIVATED FIRST COMPONENT OF COMPLEMENT BY A FRAGMENT DERIVED FROM SERUMThe Journal of Experimental Medicine, 1971
- INTERACTIONS OF THE COMPLEMENT SYSTEM WITH ENDOTOXIC LIPOPOLYSACCHARIDES IN IMMUNOGLOBULIN-DEFICIENT SERAThe Journal of Experimental Medicine, 1970
- A PLASMIN-SPLIT FRAGMENT OF C'3 AS A NEW CHEMOTACTIC FACTORThe Journal of Experimental Medicine, 1967
- FORMATION AND FUNCTIONAL SIGNIFICANCE OF A MOLECULAR COMPLEX DERIVED FROM THE SECOND AND THE FOURTH COMPONENT OF HUMAN COMPLEMENTThe Journal of Experimental Medicine, 1967
- Some physical-chemical properties of chicken γ-globulins and their pepsin and papain digestion productsImmunochemistry, 1966
- ISOLATION OF ß1F-GLOBULIN FROM HUMAN SERUM AND ITS CHARACTERIZATION AS THE FIFTH COMPONENT OF COMPLEMENTThe Journal of Experimental Medicine, 1965
- The Properdin System and Immunity: I. Demonstration and Isolation of a New Serum Protein, Properdin, and Its Role in Immune PhenomenaScience, 1954